[HTML][HTML] Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann, A Ernst… - Journal of Cancer … - Springer
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis… - Journal of cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
[PDF][PDF] Short‑term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann, A Ernst… - 2021 - d-nb.info
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann… - J. Cancer Res. Clin … - kups.ub.uni-koeln.de
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
[HTML][HTML] Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann… - Journal of Cancer …, 2022 - ncbi.nlm.nih.gov
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann… - Journal of Cancer …, 2021 - europepmc.org
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann… - Journal of Cancer …, 2022 - search.ebscohost.com
Background: Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, D Alexander, L Buschmann… - Journal of Cancer …, 2022 - search.proquest.com
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann… - J. Cancer Res. Clin … - kups.ub.uni-koeln.de
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced …
PS Plum, A Damanakis, L Buschmann… - Journal of Cancer …, 2021 - europepmc.org
Background Patients with locally advanced esophageal or gastroesophageal
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …
adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant …